Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results

Addus HomeCare (NASDAQ:ADUS - Get Free Report) issued its earnings results on Monday. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.24, Briefing.com reports. The firm had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The business's revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.84 earnings per share.

Addus HomeCare Trading Up 6.8 %

NASDAQ ADUS traded up $6.70 on Tuesday, hitting $104.59. The company's stock had a trading volume of 281,392 shares, compared to its average volume of 124,518. Addus HomeCare has a 52-week low of $78.35 and a 52-week high of $105.53. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The company's 50-day simple moving average is $98.48 and its 200 day simple moving average is $92.44. The firm has a market cap of $1.71 billion, a P/E ratio of 27.01, a PEG ratio of 1.94 and a beta of 0.96.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Royal Bank of Canada restated an "outperform" rating and issued a $102.00 target price on shares of Addus HomeCare in a research note on Thursday, February 29th. William Blair restated an "outperform" rating on shares of Addus HomeCare in a research note on Monday, February 5th. Stephens reiterated an "overweight" rating and set a $115.00 price objective on shares of Addus HomeCare in a research note on Tuesday. Oppenheimer reiterated an "outperform" rating and set a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. Finally, Barclays lowered Addus HomeCare from an "equal weight" rating to an "underweight" rating and set a $83.00 price objective on the stock. in a research note on Tuesday, April 23rd. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $106.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.